Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram
- 6 June 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 397 (2-3) , 351-357
- https://doi.org/10.1016/s0014-2999(00)00308-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Selective Serotonin Reuptake Inhibitors and CNS Drug InteractionsClinical Pharmacokinetics, 1997
- Way100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake InhibitorNeuropharmacology, 1997
- Combined Administration of a 5‐Hydroxytryptamine (5‐HT)1D Antagonist and a 5‐HT Reuptake Inhibitor Synergistically Increases 5‐HT Release in Guinea Pig Hypothalamus In VivoJournal of Neurochemistry, 1996
- Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brainEuropean Journal of Pharmacology, 1996
- Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the ratNeuropharmacology, 1995
- Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysisLife Sciences, 1994
- The 5-HT1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysisNeuropharmacology, 1994
- Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)International Clinical Psychopharmacology, 1994
- Serotonin autoreceptor subsensitivity and antidepressant activityEuropean Journal of Pharmacology, 1990